Track topics on Twitter Track topics that are important to you
(Institut Pasteur) The first global mapping of artemisinin resistance (the KARMA study) has definitively confirmed that resistance to the main drug currently used in the treatment of Plasmodium falcip...
Themis is a Vienna-based vaccine developer. Together with the Institut Pasteur, it is now planning to use a measles vaccine construct to develop and start Zika vaccine trials within the next 12 m...
Belgian drug developer Celyad has announced a strategic partnership with the Institut Curie’s Inserm…
CAMBRIDGE, MA--(Marketwired - April 29, 2016) -Biodata, producer of Labguru is thrilled to announce that after a competitive tender process, Institut national de la Read more...
Austria-based biotech Themis Bioscience has extended its existing license agreement with France’s Institut…
The first global mapping of artemisinin resistance (the KARMA study) has definitively confirmed that resistance to the main drug currently used in the treatment of Plasmodium falciparum malaria is for...
New worldwide, exclusive license agreement provides broad access to institut Pasteur's virus vector technology - Zika vaccine development progressing with high priority. Themis successfully extended i...
* Announces collaboration with Institut Curie in Paris, France, for development of its immuno-oncology program NKR-T pipeline in cellular immunotherapies for cancer Source text: http://bit.ly/1UKnRQO ...
Elie Metchnikoff passed away on July 15(th), 1916. He is considered to be the father of phagocytes, cellular innate immunity, probiotics, and gerontology. In all of these fields, he was a visionary. T...
Article highlight based on "Dynamic niche-specific adaptations in Neisseria meningitides during infection" by Yan Liu et al..